We hypothesized that MyD88 or TRIF deficiency in myeloid cells may exert opposing effects on the development of STZ-induced diabetes by differentially regulating the responses of antigen presenting cells to apoptotic beta-cells. Here, MYD88 is linked to diabetes mellitus.